Clinical trial · Interventional
Web-based Intervention for Long-term Breast Cancer Survivors
A Web-based Tailored Intervention to Improve the Quality of Life of Long-term Breast Cancer Survivors. A Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The number of breast cancer survivors is growing. More cured women are becoming long-term survivors of breast cancer (LS-BC) at least 5 years after diagnosis and after treatment has been completed. Some of these LS-BC return to daily life without any problems; however, in many cases, they experience and have to deal with physical sequelae (chronic fatigue, pain, etc.) psychological sequelae (anxiety, depression, fear of recurrence, etc.) and social sequelae (altered interpersonal relationships, difficulty in returning to work, etc.). For many LS-BC, these health problems are not being met by health professionals. Thus there is a need to promote greater continuity and coordination between specialized oncology care and primary health care in order to enhance specific follow-up of these women in the community. However, the role of the primary health care team in the provision of care in the long-term cancer survival is not clearly defined and few actions have been aimed at improving care activities, standardizing procedures and protocols, developing documentation and registries and updating the training of health care professionals. Therefore, this study aim to design, implement, and evaluate a web based tailored intervention, using artificial intelligence, to improve the quality of life of long-term breast cancer survivors, and self-efficacy for the management of late sequelae from primary care.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Long-term Effects of Cancer Treatment | — | UNRESOLVED | — |
| Long-term Effects Secondary to Cancer Therapy in Adults | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CUMACA-M Program | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention group
- description
- The CUMACA-M Program will focus on a web-based tailored intervention, using artificial intelligence, for Long-Term Survivors of Breast Cancer. It will be structured into modules related to the specific needs of LS-BS, including physical, psychological, and social needs
- interventionNames
- Other: CUMACA-M Program
- type
- NO_INTERVENTION
- label
- Control group
- description
- Usual care in the nursing consultation in primary care
Primary outcomes (3)
- measure
- Quality of life Cancer Survivor (QOL-CS)
- timeFrame
- Changes from baseline, 3-months, 6 months, and 9 month
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion Criteria: * having been diagnosed with breast cancer * having completed active oncological treatments (chemotherapy and/or radiotherapy) in a period of time greater than five years, * be free of disease at the time of data collection * be a woman and over 18 years of age * have knowledge of Internet use. Exclusion Criteria: * Women with a diagnosis of cancer other than breast cancer * Recurrence of cancer or metastasis that causes a new treatment * Being in active treatment for recurrence or new cancer * Being a man
References
Publications (1)
- DERIVEDPimentel-Parra GA, Soto-Ruiz N, Escalada-Hernandez P, San Martin-Rodriguez L, Garcia-Vivar C. EHealth intervention for quality of life in long-term breast cancer survivors: randomized controlled trial. J Natl Cancer Inst. 2026 Jun 1;118(6):1025-1031. doi: 10.1093/jnci/djag020. PMID 41581214